News
· 1hCan 2 blockbuster weight loss injectables, Wegovy & Mounjaro, fight India’s obesity curve? Listen in to the experts
With the launch of Wegovy by Danish pharmaceutical giant Novo Nordisk and US major Eli Lilly’s Mounjaro already in circulation, Indians now have two injectable therapies for obesity management. Both therapies can be effective for weight loss,
· 2hWegovy, Novo Nordisk's weight loss drug launched in India, check pricing and dosage
Wegovy is a GLP-1 receptor agonist that acts on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, improving satiety and reducing cravings for food, eventually inducing weight loss.
Sixty-three percent of patients starting on Novo Nordisk's Wegovy or Eli Lilly's Zepbound during the first quarter of 2024 ...
Diabetes drug Ozempic and weight-loss jab Wegovy may also reduce the risk of dementia, according to a new study. American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback